Idecabtagene Vicleucel,ciltacabtagene autoleucel
2seventy bio,bms,janssen
['mmsm']
limited availability, slot allocation and car-t wait list, long manufacturing failure/ times (long vein to vein time), - early on 1 slot/20 patients,
25% pts waited while on the wait list
- as of 6/2023- despite improvement, accessibility still lags #mmsm #asco2023 
Multiple Myeloma Specialist  at UTSW Harold C. Simmons Comprehensive Cancer Center | Montefiore  & Tufts Alum